Time is passing by and the COVID-19 pandemic is reaching more and more people. Across Europe, several countries have “broken” records with regard to newly infected people and this scenario is not positive for health services.
However, there seems to be a “light at the end of the tunnel”. The Oxford Vaccine was able to produce a robust immune response in people over 55.
Of the dozens of vaccines in production, some are already in advanced stages, with tests on humans. The vaccine that Russia produced, is quite successful, according to the British scientific magazine "The Lancet" but has not yet reached the "market".
Vaccine produces Antibodies that can block particles and T lymphocytes
In the case of one of the first promises, the Oxford vaccine, testing stopped in September because a patient participating in the immunity study fell ill for no apparent reason.
In the meantime, work has resumed and there seems to be good news at last! Following the tests carried out in July, it is confirmed that the Oxford vaccine produces a “robust immune response”. According to the Financial Times, the vaccine being developed by the University of Oxford can produce neutralizing antibodies. That is, these antibodies are able to block foreign particles and T lymphocytes, a type of white blood cell that destroys infected cells.
Last week a 28-year-old Brazilian doctor, who was part of the team of volunteers and took the placebo, died.
Regarding the vaccine, there is still no more concrete information. However, it is known that Portugal expects 6.9 million vaccines. If it works, the first shipment may arrive as early as December.
Several laboratories around the world are working intensively on a vaccine for COVID-19. The results are still not as expected, but there have been some developments. In the aviation area, a huge challenge may also be on the way! According to information, 8000 jumbo jets will be needed to distribute the vaccine worldwide.
-
